StockData
Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp. (TNXP) shareholders

TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3083% below fair value
$2.94+0.06 (+2.08%)

Close on Nov 17, 2026Market cap $50.42MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
54.6%
9M of 17M shares
Institutional holders
102
28 new, 5 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
8 buys · 0 sales
Net bought $479.03K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Sirenia Capital Management LP
Joint filing with Alex Silverstein (8.80%)
1,297,4708.80%13G (passive)Mar 31, 2026
Point72 Asset Management, L.P.
Joint filing with Point72 Capital Advisors, Inc. (9.20%), Steven A. Cohen (9.20%)
1,235,0589.20%13G (passive)Dec 29, 2025
Point72 Capital Advisors, Inc.
Joint filing with Point72 Asset Management, L.P. (6.90%), Steven A. Cohen (6.90%)
1,100,9646.90%13G (passive) amendmentMar 31, 2026
Millennium Management LLC
Joint filing with Millennium Group Management LLC (5.60%), Israel A. Englander (5.60%)
890,3665.60%13G (passive)Jun 9, 2026
AQR Capital Management Holdings, LLC
Joint filing with AQR Capital Management, LLC (5.54%)
882,5955.54%13G (passive)Jun 30, 2026
BlackRock, Inc.854,5796.70%13G (passive) amendmentDec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of TNXPValueChange% of portfolio
BlackRock, Inc.1,398,0418.15%$17.84M+429,8640.00%
Point72 Asset Management, L.P.1,166,7526.80%$14.89M+1,041,3380.02%
Millennium Management LLC966,9325.64%$12.34M+747,2590.00%
Aqr Capital Management LLC882,5955.15%$11.26M+721,3870.00%
Vanguard Capital Management LLC691,8954.03%$8.83M+173,2450.00%
Jones Hill Capital LP625,4283.65%$7.98M+173,3121.70%
Geode Capital Management, LLC395,2602.30%$5.04M+81,9690.00%
Ishara Investments LP338,2501.97%$4.32MNew3.17%
State Street Corp271,3741.58%$3.46M+40,7670.00%
UBS Group AG231,6821.35%$2.96M+40.00%
Citadel Advisors LLC195,8591.14%$2.50M−272,8530.00%
Essex Investment Management Co LLC165,1440.96%$2.11MNew0.28%
Balyasny Asset Management L.P.132,5910.77%$1.69M−180,4910.00%
Northern Trust Corp120,3860.70%$1.54M+20,2520.00%
Nuveen, LLC117,4470.68%$1.50M+22,8860.00%
Vanguard Fiduciary Trust Co102,0540.60%$1.30M+17,7840.00%
Goldman Sachs Group Inc98,3560.57%$1.26M+45,3010.00%
Vanguard Portfolio Management LLC97,9540.57%$1.25M+19,3270.00%
FMR LLC93,5510.55%$1.19M+91,8130.00%
Ieq Capital, LLC92,3730.54%$1.18M+78,0150.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20261029M54.6%28 / 518 / 55M0M
Q1 2026815M28.4%20 / 3116 / 83M1M
Q4 2025704M21.8%17 / 349 / 72M0M
Q3 2025602M13.8%18 / 239 / 51M0M
Q2 2025471M8.1%27 / 106 / 51M0M
Q1 2025250M2.8%24 / 01 / 10M0M
Q4 202420M0.0%2 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

100 funds held TNXP in Q2 2026, 67% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of TNXPValue% of fundAs of
Vanguard Total Stock Market Index Fund488,1082.85%$6.23M0.00%Jun 30, 2026
iShares Russell 2000 ETF389,9312.27%$4.98M0.01%Jun 30, 2026
Vanguard Extended Market Index Fund187,4141.09%$2.39M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund158,8290.93%$1.59M0.00%Jul 31, 2026
iShares Russell 2000 Value ETF145,8200.85%$1.86M0.01%Jun 30, 2026
Fidelity Enhanced Small Cap Core ETF78,3420.46%$999.64K0.02%Jun 30, 2026
1290 Essex Small Cap Growth Fund73,8400.43%$739.14K0.64%Jul 31, 2026
Vanguard Russell 2000 Index Fund69,3380.40%$854.94K0.00%May 31, 2026
College Retirement Equities Fund - Total Global Stock Account54,9200.32%$700.78K0.00%Jun 30, 2026
iShares Micro-Cap ETF49,0850.29%$626.32K0.04%Jun 30, 2026
Schwab Small-Cap Index Fund36,3010.21%$363.37K0.00%Jul 31, 2026
Fidelity Extended Market Index Fund35,5650.21%$438.52K0.00%May 31, 2026
Nuveen Equity Index Fund31,0790.18%$311.10K0.00%Jul 31, 2026
Master Small Cap Index Series29,3540.17%$374.56K0.01%Jun 30, 2026
AQR Small Cap Multi-Style Fund22,6480.13%$288.99K0.08%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Seth LedermanChief Executive Officer, Director36,0070.21%Nov 12, 2026
Thomas EngleseChief Commercial Officer6940.00%Sep 8, 2026
Bradley SaengerChief Financial Officer2,1540.01%Jul 9, 2026
Siobhan FogartyChief Technology Officer10.00%Feb 26, 2026
Gregory M. SullivanChief Medical Officer0–Feb 26, 2026
Jessica Edgar MorrisChief Operating Officer0–Feb 26, 2026
Richard H. BaggerDirector1,0000.01%Aug 24, 2026
Carolyn E. TaylorDirector1,8330.01%Jun 15, 2026
Richard Newcomb StillwellDirector5,0000.03%Jun 9, 2026
James Randolph Hunter JrDirector––May 14, 2026
Adeoye Y. OlukotunDirector0–May 14, 2026
Margaret Smith BellDirector0–May 14, 2026
David L. GrangeDirector––May 14, 2026
James TrecoDirector2500.00%May 14, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Seth Lederman
Chief Executive Officer, Director
Nov 11, 2026Buy+5,000$4.05$20.28K16,005
Seth Lederman
Chief Executive Officer, Director
Aug 27, 2026Buy+2,000$13.79$27.58K11,005
Richard H. Bagger
Director
Aug 20, 2026Buy+1,000$12.60$12.60K1,000
Bradley Saenger
Chief Financial Officer
Jun 30, 2026Other+1,453$10.91$15.85K2,154
Carolyn E. Taylor
Director
Jun 12, 2026Buy+1,415$10.55$14.93K1,833
Seth Lederman
Chief Executive Officer, Director
Jun 9, 2026Buy+5,000$11.79$58.95K9,005
Richard Newcomb Stillwell
Director
Jun 8, 2026Buy+5,000$11.65$58.25K5,000
Seth Lederman
Chief Executive Officer, Director
Mar 31, 2026Buy+5,000$12.62$63.10K20,001
Seth Lederman
Chief Executive Officer, Director
Mar 18, 2026Buy+15,000$14.89$223.35K15,001
Bradley Saenger
Chief Financial Officer, 10% owner
Dec 31, 2025Award+701$13.42$9.41K701
Carolyn E. Taylor
Director
Aug 21, 2025Buy+418$36.03$15.06K418
James Treco
Director
Aug 20, 2025Buy+250$36.00$9.00K250
Seth Lederman
Chief Executive Officer, Director
May 15, 2025Buy+4,000$21.55$86.20K4,005
Margaret Smith Bell
Director
Feb 5, 2025Other−1$0.15$00
James Treco
Director
Feb 5, 2025Other−0.02$0.30$00
Richard H. Bagger
Director
Feb 5, 2025Other−0.02$0.20$00
Gregory M. Sullivan
Chief Medical Officer
Feb 5, 2025Other−0.11$1.47$00
Jessica Edgar Morris
Chief Operating Officer
Feb 5, 2025Other−1––0
Bradley Saenger
Chief Financial Officer
Feb 5, 2025Other−0.04––0
Seth Lederman
Chief Executive Officer, Director
Feb 5, 2025Other−0.22$3.30$11
Seth Lederman
Chief Executive Officer, Director
Feb 5, 2025Other−5.18$3.38$185
Seth Lederman
Chief Executive Officer, Director
Feb 5, 2025Other−1$0.15$00
Adeoye Y. Olukotun
Director
Jun 10, 2024Other−0.81$1.91$20
Seth Lederman
Chief Executive Officer, Director
Jun 29, 2022Buy+20,000$1.71$34.20K24,235
Seth Lederman
Chief Executive Officer, Director
Mar 25, 2022Buy+100,000$0.25$25.00K112,177
Seth Lederman
Chief Executive Officer, Director
Sep 28, 2021Buy+12,000$0.61$7.32K12,177
Bradley Saenger
Chief Financial Officer
Jun 30, 2021Award+18,248$0.58$10.58K19,645
Gregory M. Sullivan
Chief Medical Officer
Jun 30, 2021Award+36,496$0.58$21.17K99,223
Daniel Wintner Goodman
Director
May 25, 2021Buy+5,000$1.12$5.60K5,001
Seth Lederman
Chief Executive Officer, Director
Mar 24, 2021Buy+16,733$1.32$22.09K135,000
Gregory M. Sullivan
Chief Medical Officer
Jan 7, 2021Award+41,322$0.51$21.07K62,727
Seth Lederman
Chief Executive Officer, Director
Dec 30, 2020Buy+35,000$0.68$23.80K118,267
James Treco
Director
Aug 31, 2020Buy+5,500$0.89$4.90K10,000
Margaret Smith Bell
Director
Aug 20, 2020Buy+5,391$0.93$5.01K5,391
Gregory M. Sullivan
Chief Medical Officer
Aug 17, 2020Buy+20,000$1.03$20.60K21,405
James Treco
Director
Aug 14, 2020Buy+4,500$1.06$4.77K4,500
Adeoye Y. Olukotun
Director
Aug 13, 2020Buy+5,350$0.94$5.03K5,350
Richard H. Bagger
Director
Aug 13, 2020Buy+10,000$0.91$9.10K10,000
Seth Lederman
Chief Executive Officer, Director
Aug 13, 2020Buy+60,000$0.91$54.60K83,267
Bradley Saenger
Chief Financial Officer
Jan 6, 2020Award+493$1.02$5031,397
Seth Lederman
Chief Executive Officer, Director
Dec 3, 2019Buy+20,000$1.16$23.20K23,267
Gregory M. Sullivan
Chief Medical Officer
Jul 31, 2019Award+1,142$11.82$13.50K1,405
Bradley Saenger
Chief Financial Officer
Jul 31, 2019Award+815$11.82$9.63K904
Seth Lederman
Chief Executive Officer, Director
Mar 29, 2019Buy+5,000$2.49$12.45K32,670
Seth Lederman
Chief Executive Officer, Director
Mar 26, 2019Buy+25,000$2.38$59.50K27,670
Gregory M. Sullivan
Chief Medical Officer
Feb 17, 2019Award+59$17.85$1.05K1,405
Bradley Saenger
Chief Financial Officer
Feb 17, 2019Award+59$17.85$1.05K904
Seth Lederman
Chief Executive Officer, Director
Jun 29, 2018Buy+500$4.64$2.32K17,666
Seth Lederman
Chief Executive Officer, Director
Jun 28, 2018Buy+500$4.58$2.29K17,166
Seth Lederman
Chief Executive Officer, Director
Jun 27, 2018Buy+500$4.55$2.28K16,666
Ernest Mario
Director
Jun 25, 2018Buy+16,500$4.48$73.92K50,000
Gregory M. Sullivan
Chief Medical Officer
Jun 14, 2018Buy+10,000$3.97$39.70K20,482
Bradley Saenger
Chief Financial Officer
Jun 14, 2018Buy+300$4.10$1.23K3,079
Jessica Edgar Morris
Chief Operating Officer
Jun 14, 2018Buy+300$4.19$1.26K1,638
Seth Lederman
Chief Executive Officer, Director
Jun 12, 2018Buy+2,000$4.37$8.74K20,463
Seth Lederman
Chief Executive Officer, Director
Jun 12, 2018Buy+1,000$4.37$4.37K16,166
John B. Rhodes
Director
Jun 1, 2018Buy+7,500$3.33$24.98K23,470
Seth Lederman
Chief Executive Officer, Director
May 25, 2018Buy+4,000$3.17$12.68K26,700
Charles E. Mather Iv
Director
Feb 27, 2018Option exercise+750––12,580
Ernest Mario
Director
Feb 9, 2018Gift+10,000––33,500

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
19.40%
3M shares short
Days to cover
4.1
At 1M shares a day
Change since last report
+12.8%
From 3M shares
Short volume, 20 days
56.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Tonix Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 24,705 shares on Aug 21, 2026 over the last 90 days.

See a number that looks wrong?